Pliant Therapeutics, Inc.

NASDAQ:PLRX

15.19 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q1
Operating Activities:
Net Income -57.763-55.854-46.955-41.109-41.487-41.192-37.548-35.06-30.615-29.546-28.1-24.531-27.045-22.831-22.856-19.027-16.534-17.00111.02942.169-13.255-15.522-14.023-6.222
Depreciation & Amortization 0.5320.6220.5130.4640.4480.4770.4520.4550.4540.4590.4550.4180.3880.370.3590.3470.330.3210.3120.290.2870.280.2560.118
Deferred Income Tax 0007.631-3.703-3.928000000000000000000
Stock Based Compensation 8.89910.6449.6669.15210.36213.04611.92310.8554.8093.4033.5312.7682.8112.282.5781.5151.1690.7860.4250.5310.480.5060.3120.027
Change In Working Capital -3.021-1.7124.7330.609-2.4416.211-3.128-6.5456.9850.6773.1-0.5370.9510.525.9830.414-0.75723.666-24.532-6.246-2.3880.9652.608-0.913
Accounts Receivables 00001.581.717-1.314-0.5013.507-3.740.749-0.3880.220.3447.105-2.148-3.53228.163-24.71-7.0520000
Change In Inventory 000000000000.40100-262.0743.4791.636-3.697-1.0021.9480000
Change In Accounts Payables 3.727-3.6262.2571.1721.0590.882-0.144-1.6050.052-1.5681.770.49-0.340.0760.665-0.9041.151-0.5011.176-1.467-1.6030.0471.7680
Other Working Capital -4.391.9142.476-0.563-5.083.6121.458-4.4393.4265.9850.581-1.041.0710.1260.287-0.013-0.012-0.2990.0040.325-0.7850.9180.84-0.913
Other Non Cash Items 19.0816.51710.207-1.8490.5970.627-1.975-0.944-0.1310.440.5162.0170.3850.2580.2710.2661.151-0.3231.248-1.28-1.6650.1521.705-0.597
Operating Cash Flow -32.273-45.297-30.271-25.102-36.224-24.759-30.276-31.239-18.498-24.396-20.498-19.865-22.51-19.403-13.665-16.485-15.7927.772-12.76636.744-14.876-13.771-10.847-7.587
Investing Activities:
Investments In Property Plant And Equipment -0.896-1.251-1.492-0.061-0.094-0.603-0.163-0.166-0.696-0.254-0.644-0.592-0.48-0.639-0.242-0.587-0.323-0.286-0.336-0.184-0.048-0.474-0.258-0.89
Acquisitions Net 000-158.073-38.34722.375174.045-20.188177.55600000023.99700000000
Purchases Of Investments -77.033-48.522-52.375-57.497-114.476-134.476-276.62-36.314-211.354-38.82-39.228-37.92-43.135-74.026-64.806-54.781-126.757-130.03-11.037-16.974-2.057-5.777-27.1590
Sales Maturities Of Investments 108.88960.475113.41389.479152.823112.101102.57556.50233.79845.56941.40364.29575.71578.24977.2867.2742223.99707.97715.852000
Other Investing Activites 011.95361.038158.07338.347-22.375-174.04520.188-177.5566.7492.17526.37532.584.22312.474-23.997-104.75723.997-0.029-8.99713.79511.171-27.1590
Investing Cash Flow 30.9610.70259.54631.92138.253-22.978-174.20820.022-178.2526.4951.53125.78332.13.58412.23211.906-105.08-106.319-11.373-9.18113.7474.92-27.417-0.89
Financing Activities:
Debt Repayment -19.9090-19.9090000-0.150-9.8500000000000000
Common Stock Issued 0.5430.6841.8790.2324.7690.161270.2510.055217.5060.576-0.1530.5412.4430.1921.37153.119-2.36800-0.1460.014000
Common Stock Repurchased 0000000000000000-2.3650000000
Dividends Paid 000000000000000000000000
Other Financing Activities 19.9090.6841.879-0.013-0.075-0.173-0.5860.379-1.209-0.021-0.153-0.025-1.9940.1921.37-152.8820.003163.6451.746.831-0.394-0.771-0.12719.484
Financing Cash Flow 0.5430.68421.7880.2190.6990.161273.3260.284216.29710.426-0.1530.5160.4490.1921.370.237-2.365163.6451.746.831-0.394-0.771-0.12719.484
Other Information:
Effect Of Forex Changes On Cash 0001.362-1.3620000000000000000000
Net Change In Cash 0.712-33.91151.0635.5552.728-47.57668.842-10.93319.547-7.475-19.126.43410.039-15.627-0.063-4.342-123.23765.09327.56174.394-1.523-9.622-38.39111.007
Cash At End Of Period 81.09880.386114.29763.23457.67954.951102.52733.68444.61725.0732.54551.66545.23135.19250.81950.88255.224178.461113.36885.80711.41312.93622.55815.258